In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Expected publication date

Area of interest

Type

Showing 131 to 140 of 377

TitleTypeExpected publication date
Fidanacogene elaparvovec for treating moderately severe to severe haemophilia B [ID4032]Technology appraisal guidanceTBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction ID6514Technology appraisal guidanceTBC
Flow tDCSMedtech innovation briefingsTBC
Fordadistrogene movaparvovec for treating Duchenne muscular dystrophy [ID6133]Technology appraisal guidanceTBC
Fruquintinib for previously treated metastatic colorectal cancer ID6274Technology appraisal guidanceTBC
Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6394]Technology appraisal guidance
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic painMedical technologies guidanceTBC
Giroctocogene fitelparvovec for treating moderately severe to severe haemophilia A ID6312Technology appraisal guidanceTBC
Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]Technology appraisal guidance
Glaucoma - lerdelimumab (CAT-152) [ID383]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All